Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial (Q33724456)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial |
scientific article |
Statements
1 reference
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial (English)
1 reference
Edith A Perez
1 reference
George W Sledge
1 reference
Vera J Suman
1 reference
James N Ingle
1 reference
Eric P Winer
1 reference
Silvana Martino
1 reference
Clifford A Hudis
1 reference
Julie R Gralow
1 reference
Nancy E Davidson
1 reference
Peter A Kaufman
1 reference
Shaker R Dakhil
1 reference
Karen A Gelmon
1 reference
Bernard J Gersh
1 reference
Allan S Jaffe
1 reference
Richard J Rodeheffer
1 reference
4 February 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference